Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo del documento
Intervalo de año de publicación
1.
J Clin Psychiatry ; 47(2): 66-70, 1986 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-3944066

RESUMEN

To test the hypothesis that 2-phenylethylamine (PEA) modulates affect, plasma levels and urinary excretion of its main metabolite, phenylacetic acid (PAA), were studied in depressed and manic subjects, and the mood-elevating effects of its precursor, L-phenylalanine, were studied in depressed subjects. Mean total plasma PAA concentrations were 491.83 +/- 232.84 ng/ml in 12 healthy volunteers and 300.33 +/- 197.44 ng/ml in 23 drug-free patients with major depression. The 24-hour urinary PAA excretion was also measured in 48 healthy volunteers (141.1 +/- 10.2 mg PAA/24 hr) and in 144 patients with major depression (78.2 +/- 41.0 mg PAA/24 hr). The results suggest that low plasma and urinary PAA may be state markers for depression and are compatible with the PEA hypothesis. In further support, phenylalanine elevated mood in 31 of 40 depressives.


Asunto(s)
Trastorno Depresivo/etiología , Dieta , Fenetilaminas/metabolismo , Fenilacetatos/metabolismo , Fenilalanina/administración & dosificación , Adulto , Atención Ambulatoria , Trastorno Bipolar/etiología , Trastorno Bipolar/metabolismo , Trastorno Bipolar/psicología , Trastorno Depresivo/metabolismo , Trastorno Depresivo/psicología , Emociones/efectos de los fármacos , Femenino , Hospitalización , Humanos , Masculino , Persona de Mediana Edad , Fenilacetatos/sangre , Fenilacetatos/orina , Fenilalanina/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA